Frontier Biotechnologies Inc. Class ASSE: 688221

Announcement on the Renewal of Company Product Albuvirtide for Injection for Inclusion in the Catalogue of Drugs for Basic National Medical Insurance

· Issued by Frontier Biotechnologies Inc. Class A via Shanghai Stock Exchange
Announcement on the Renewal of Company Product Albuvirtide for Injection for Inclusion in the Catalogue of Drugs for Basic National Medical Insurance

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis